Home > Insider Trading > Filing (0001400482-16-000219)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1400482	Acucela Inc.	M??????	Pharmaceutical Preparations (2834)	020592619

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1651281	Lukas Scheibler	C/O Acucela Inc. 1301 Second Ave., Suite 4200 Seattle WA 98101	Evp Of Research & Development	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-08-17	31,962	$0.00	31,962	No	4	M	Direct
Common Stock	Disposition	2016-08-18	31,962	$10.81	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Disposition	2016-08-17	31,962	$0.00	31,962	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
95,885			No	4	M	Direct

Footnotes

The issuer's common stock trades on the Tokyo Stock Exchange under the symbol referenced in the issuer's registration statement on Form S-1 (File No. 333-192900).
Each restricted stock unit (RSU) represents a contingent right to receive (1) share of the issuer's common stock upon settlement. This transaction represents the settlement of RSUs in shares of common stock on their scheduled vesting date.
The shares were sold at a price of 1082 Japanese Yen. The U.S. per share price in this Column 4 reflects the average of the buy and sell Japanese Yen-to U.S. Dollar exchange rates on the transaction date divided by the number of shares sold. These shares were sold in multiple transactions at prices ranging from 1054 to 1120 Japanese Yen, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
On August 17, 2015, the reporting person was granted 127,847 RSUs, four year vesting period, with twenty-five percent (25%) of the RSUs vesting on August 17, 2016, and the remainder vesting thereafter ona monthly pro-rata basis, such that 100% of the RSUs are vested on August 17, 2019, subject to the reporting person's continuing employment through the applicable vesting date.